Export

Shire Human Genetic Therapies AB

Financial information

The information source is the annual report of the company with business id 556591-1764

* Closing information (×1000) SEK

Fiscal year 202403 202303 202203
Number of months: 12 12
Turnover: 0 0 Revenue Down 3,914
Financial expenses: 0 0 0
Earnings before taxes: 965 Revenue Up 822 Revenue Up 95
Total assets: 26,506 Revenue Up 25,546 Revenue Up 24,730
Current assets: 26,506 Revenue Up 25,546 Revenue Up 24,728
Current liabilities: 362 Revenue Up 174 Revenue Up 10
Equity capital: 26,144 Revenue Up 25,372 Revenue Up 24,720
Share capital: 1,000 1,000 1,000
Number of employees: 0 0 0

Financial ratios

Solvency: 98.6% Revenue Down 99.3% Revenue Down 100.0%
Turnover per employee: NaN NaN Infinity
Profitability: Infinity% Infinity% Revenue Up 2.4%
Return on equity (ROE): 3.7% Revenue Up 3.2% Revenue Up 0.4%
Current ratio: 7.322.1% Revenue Down 14.681.6% Revenue Down 247.280.0%
Return on assets (ROA): 3.6% Revenue Up 3.2% Revenue Up 0.4%

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202403
Number of months: 12
Turnover: 0
Financial expenses: 0
Earnings before taxes: 965
Total assets: 26,506
Current assets: 26,506
Current liabilities: 362
Equity capital: 26,144
Share capital: 1,000
Number of employees: 0

Financial ratios

Solvency: 98.6%
Turnover per employee: NaN
Profitability: Infinity%
Return on equity (ROE): 3.7%
Current ratio: 7.322.1%
Return on assets (ROA): 3.6%